JP2025514630A - 粘膜付着性とウイルス結合性を有する二官能性ペプチド - Google Patents

粘膜付着性とウイルス結合性を有する二官能性ペプチド Download PDF

Info

Publication number
JP2025514630A
JP2025514630A JP2024558035A JP2024558035A JP2025514630A JP 2025514630 A JP2025514630 A JP 2025514630A JP 2024558035 A JP2024558035 A JP 2024558035A JP 2024558035 A JP2024558035 A JP 2024558035A JP 2025514630 A JP2025514630 A JP 2025514630A
Authority
JP
Japan
Prior art keywords
seq
peptide
binding site
mucin
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024558035A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025514630A5 (enExample
Inventor
ラウスター・ダニエル
ディーン・ロビン
ポヴォロツキー・タチアナ
バルドゥア・マルクス
ハッケンベルガー・クリスティアン
フロレス・セバスチャン
マリー・ヤン
ヘルマン・アンドレアス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forschungsverbund Berlin
Original Assignee
Forschungsverbund Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forschungsverbund Berlin filed Critical Forschungsverbund Berlin
Publication of JP2025514630A publication Critical patent/JP2025514630A/ja
Publication of JP2025514630A5 publication Critical patent/JP2025514630A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/17—Metallocarboxypeptidases (3.4.17)
    • C12Y304/17023—Angiotensin-converting enzyme 2 (3.4.17.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
JP2024558035A 2022-04-01 2023-03-31 粘膜付着性とウイルス結合性を有する二官能性ペプチド Pending JP2025514630A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22166380 2022-04-01
EP22166380.0 2022-04-01
PCT/EP2023/058432 WO2023187142A1 (en) 2022-04-01 2023-03-31 Bifunctional peptide with mucoadhesive and virus binding properties

Publications (2)

Publication Number Publication Date
JP2025514630A true JP2025514630A (ja) 2025-05-09
JP2025514630A5 JP2025514630A5 (enExample) 2026-04-14

Family

ID=81448252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024558035A Pending JP2025514630A (ja) 2022-04-01 2023-03-31 粘膜付着性とウイルス結合性を有する二官能性ペプチド

Country Status (9)

Country Link
US (1) US20250250312A1 (enExample)
EP (1) EP4504342B1 (enExample)
JP (1) JP2025514630A (enExample)
KR (1) KR20240166574A (enExample)
CN (1) CN119677782A (enExample)
AU (1) AU2023246944A1 (enExample)
CA (1) CA3254872A1 (enExample)
ES (1) ES3073237T3 (enExample)
WO (1) WO2023187142A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4684804A1 (en) 2024-07-26 2026-01-28 Freie Universität Berlin Conjugation product comprising an antigen binding moiety and a mucin binding moiety

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021190980A1 (en) * 2020-03-22 2021-09-30 Quadrucept Bio Limited Multimers for viral strain evolution
WO2021257781A1 (en) * 2020-06-19 2021-12-23 Vast Sea Biotechnology, Inc. Compositions and methods for treating covid-19

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021190980A1 (en) * 2020-03-22 2021-09-30 Quadrucept Bio Limited Multimers for viral strain evolution
WO2021257781A1 (en) * 2020-06-19 2021-12-23 Vast Sea Biotechnology, Inc. Compositions and methods for treating covid-19

Also Published As

Publication number Publication date
US20250250312A1 (en) 2025-08-07
AU2023246944A1 (en) 2024-10-10
KR20240166574A (ko) 2024-11-26
EP4504342C0 (en) 2026-04-29
CA3254872A1 (en) 2023-10-05
CN119677782A (zh) 2025-03-21
EP4504342A1 (en) 2025-02-12
EP4504342B1 (en) 2026-04-29
WO2023187142A1 (en) 2023-10-05
ES3073237T3 (en) 2026-07-09

Similar Documents

Publication Publication Date Title
WO2024213127A1 (en) Fusion lipopeptide for inhibiting coronavirus
WO2022202816A1 (ja) ペプチド及びペプチドを含む組成物
US20250250312A1 (en) Bifunctional peptide with mucoadhesive and virus binding properties
Chung et al. Preventive and therapeutic effects of a super-multivalent sialylated filamentous bacteriophage against the influenza virus
EP3210995B1 (en) Hemagglutinin-binding peptide
CA3234324A1 (en) Peptide
US12534514B2 (en) Biological and synthetic molecules inhibiting respiratory syncytial virus infection
JP7854211B2 (ja) ヘマグルチニン結合ペプチド
JP6921002B2 (ja) ペプチド模倣化合物を中和するインフルエンザウイルス
JP2013071904A (ja) 抗インフルエンザウイルス活性を有するペプチド
CN110234337A (zh) 中和流感病毒的化合物
AU2022206101A1 (en) Anti-infective bicyclic peptide ligands
JP7185874B2 (ja) 抗ウイルス剤としてのラビリントペプチン
EA039991B1 (ru) Соединения-пептидомиметики, нейтрализующие вирус гриппа

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260331

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260331

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20260331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260406

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260714